Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03723616 · ClinicalTrials.gov registry record · NA
Reactions to Warnings on Hookah Ads
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 2,588
- Enrollment target
NCT03723616: Completed NA study, sponsored by Duke University.
NCT03723616 is a NA study that has completed, run by Duke University. The registered enrollment target is 2,588 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03723616, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,588 participants
- Enrollment target
Study Summary
The purpose of this study is to help us better understand what kinds of waterpipe tobacco advertisements appeal to young adults as well as to help evaluate and create health warnings that can be placed on waterpipe tobacco advertisements to inform young adults of the risks associated with smoking hookah tobacco.
Primary Outcome
Participants rated on 7-point bipolar scales the extent each ad made them feel not at all anxious/very anxious, not at all worried/very worried, not at all fearful/very fearful and good /bad. Reported as a composite score created by averaging the items. Mean scores range from 1 to 7 where higher mean values represent more negative emotional reactions to viewing the ad.
Interventions
- BEHAVIORAL Ads Only
- BEHAVIORAL Ads with text-only health warning labels (HWLs)
- BEHAVIORAL Ads with text + graphic health warning labels (HWLs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,588 participants |
| Start Date | 2018-10-05 |
| Est. Completion | 2021-03-26 |
| Phase | NA |
What the finished NCT03723616 record still lists
NCT03723616 is an interventional study that assigns participants to a tested intervention. Its 2,588 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% higher).
The record links to 0 conditions, and to 3 interventions - of which Ads Only is the first listed.
NCT03723616 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03723616 about?
NCT03723616 is a clinical study titled "Reactions to Warnings on Hookah Ads". The purpose of this study is to help us better understand what kinds of waterpipe tobacco advertisements appeal to young adults as well as to help evaluate and create health warnings that can be placed on waterpipe tobacco advertisements to inform young adults of the risks associated with smoking ho...
What is the current status of trial NCT03723616?
This trial is currently completed. It is a NA study. The enrollment target is 2,588 participants. The study started on 2018-10-05. Estimated completion is 2021-03-26.
What interventions are being tested in trial NCT03723616?
The interventions under investigation include: Ads Only (BEHAVIORAL), Ads with text-only health warning labels (HWLs) (BEHAVIORAL), Ads with text + graphic health warning labels (HWLs) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03723616?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03723616's enrollment target sits among peer trials
2,588 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06370520 · 2,592 participants
Screening Emotions in Adolescents at the Hospital for mTBI
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- NCT06574672 · 2,600 participants · NA
Embedded Palliative Care in the MICU
- NCT06018285 · 2,572 participants · NA
Stepped Approach to Reducing Risk of Suicide in Primary Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI